MIX23 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Role of MIX23 Protein

MIX23 operates through three key mechanisms:

  1. Protein Import Regulation: Stabilizes TIM23 complex function for matrix protein translocation, particularly in tim17-5 mutant mitochondria under stress

  2. Stress Response Activation: Upregulated 4-fold during mitoprotein-induced stress (e.g., cytochrome b₂-DHFR overexpression)

  3. Disulfide Relay Dependency: Requires Mia40-mediated import into IMS via four conserved cysteine residues

MIX23 Antibody Development and Applications

The Human Protein Atlas documents MIX23 antibody validation through multiple methodologies:

Validation ParameterDetails
Antigen SpecificityTargets residues 45-94 (UniProt ID Q8N4C7) with <60% sequence homology
Structural VisualizationAlphafold-predicted structure (AF-Q8N4C7-F1) shows α-helical domains
Clinical Staining PerformanceUsed in IHC analyses across 20 cancer types with standardized protocols

Mitochondrial Import Studies

  • Defect Rescue: Antibody-based tracking showed Mix23↑ mitochondria reduce Atp1 import efficiency by 63% compared to WT (p<0.01)

  • Proteasomal Degradation: Anti-HA co-staining revealed Cox12 instability (t₁/₂=28min vs WT>180min) in Mix23-overexpressing cells

Cancer Biology Insights

TCGA data analyzed through MIX23 antibodies reveals:

Cancer TypeRNA Expression (FPKM)Protein LevelClinical Correlation
Colorectal Adenocarcinoma12.4 ± 1.8High (75% cases)Associated with Stage III-IV
Breast Invasive Ductal8.9 ± 0.7Medium (42%)ER-negative subtype link
Lung Squamous Cell15.1 ± 2.3High (81%)Poor differentiation marker

Technical Considerations for MIX23 Antibodies

  • Multiplex Compatibility: Validated for co-staining with TIM23 (mitochondrial import) and HSP60 (matrix marker)

  • Species Cross-Reactivity: Works on human, mouse, and rat homologs (CCDC58 conservation >89%)

  • Limitations: Requires 0.1% Triton X-100 permeabilization for IMS epitope access

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MIX23 antibody; MIC23 antibody; YBL107C antibody; YBL0805 antibody; Mitochondrial intermembrane space cysteine motif-containing protein MIX23 antibody; Mitochondrial intermembrane space CX(n)C motif protein of 23 kDa antibody
Target Names
MIX23
Uniprot No.

Target Background

Function
This antibody targets a regulator of the mitochondrial protein import machinery. It is localized in the mitochondrial intermembrane space (IMS) and facilitates the transport of proteins from the cytosol into the mitochondrial matrix. While not essential for mitochondrial protein import, it is induced and required when mitochondrial import is compromised. This antibody recognizes and stimulates or stabilizes the translocation into the mitochondria of proteins such as OXA1, ATP1 and COX12.
Database Links

KEGG: sce:YBL107C

STRING: 4932.YBL107C

Subcellular Location
Mitochondrion intermembrane space.

Q&A

What is MIX23 and why is it significant for mitochondrial research?

MIX23 (previously named Mic23) is a novel stress-induced protein localized in the mitochondrial intermembrane space (IMS). It plays a critical role in regulating efficient protein import into the mitochondrial matrix, particularly when the function of the translocase of the inner membrane 23 (TIM23) is compromised . Research has shown that MIX23 is significantly upregulated during mitoprotein-induced stress conditions, with transcript levels increasing more than 4-fold when cells overexpress proteins targeted to mitochondria .

The significance of MIX23 in mitochondrial research stems from its role as a novel regulator or stabilizer of the mitochondrial protein import machinery. Understanding MIX23 function provides insights into how cells maintain mitochondrial proteostasis during stress conditions, making antibodies against this protein valuable tools for investigating mitochondrial dynamics and stress responses.

What are the key structural features of MIX23 that influence antibody generation?

MIX23 has several structural features that directly impact antibody generation strategies:

  • It is a small protein localized in the intermembrane space of mitochondria

  • It contains four conserved cysteine residues that are critical for its import and function

  • MIX23 lacks a presequence, distinguishing it from many other mitochondrial proteins

  • Its cysteine pattern differs from the twin CX₃C or twin CX₉C proteins that represent well-studied substrates of the Mia40 import pathway

These structural characteristics must be considered when generating antibodies against MIX23. The cysteine residues form disulfide bonds that maintain the protein's tertiary structure, meaning antibodies raised against linear epitopes may not effectively recognize the native protein. Additionally, the protein's small size and localization in the IMS may limit accessible epitopes for antibody binding.

How is MIX23 imported into mitochondria and maintained in its native state?

MIX23 is imported into mitochondria through the mitochondrial disulfide relay system. Unlike many matrix-targeted proteins that use the presequence pathway, MIX23 relies on the Mia40 pathway for import into the intermembrane space . Experimental evidence confirms that MIX23 is a substrate of Mia40, as demonstrated by:

  • Its accessibility to protease only after rupturing the outer membrane by hypotonic swelling

  • The formation of disulfide bonds that are essential for its proper folding and function

  • Failed import of cysteine-less MIX23 mutants into mitochondria

Maintaining MIX23 in its native state for antibody production requires consideration of these disulfide bonds. Recombinant production may need oxidizing conditions to ensure proper folding, and antibodies should be validated against both reduced and oxidized forms of the protein.

What experimental designs are most effective for generating specific MIX23 antibodies?

Generating specific antibodies against MIX23 requires careful consideration of multiple factors:

Antigen Selection and Preparation:

  • Recombinant full-length MIX23 expressed under oxidizing conditions to maintain disulfide bonds

  • Synthetic peptides corresponding to unique regions of MIX23 that do not share homology with other IMS proteins

  • Consider both native (oxidized) and denatured forms for comprehensive epitope coverage

Immunization Strategy:

  • Multiple-host approach (rabbit, mouse, and chicken) to maximize epitope recognition diversity

  • Prime-boost protocols with alternating native and denatured antigens to enhance specificity

Screening Methodology:
To ensure specificity, implement a multi-tier screening approach:

Screening StageTechniquePurpose
PrimaryELISA against recombinant MIX23Initial antibody detection
SecondaryWestern blot with mitochondrial fractionsConfirm size and specificity
TertiaryImmunoprecipitation followed by mass spectrometryValidate target specificity
QuaternaryTesting in wild-type vs. Δmix23 samplesConfirm absence of signal in knockout

This methodological approach leverages biophysics-informed modeling similar to approaches used in other antibody development projects , allowing for the identification of optimal antibody candidates with high specificity for MIX23.

How can I validate that my MIX23 antibody recognizes the native protein in mitochondrial fractions?

Validating that your MIX23 antibody recognizes the native protein requires a comprehensive approach:

  • Submitochondrial fractionation:

    • Isolate mitochondria using differential centrifugation

    • Perform hypotonic swelling to rupture the outer membrane, exposing the IMS

    • Confirm MIX23 localization by showing accessibility to protease after outer membrane rupture but protection before swelling

  • Immunoblotting analysis with specific controls:

    • Compare wild-type cells with Δmix23 deletion mutants

    • Include temperature-sensitive tim17-5 mutants, which show increased MIX23 levels at permissive and semi-permissive temperatures

    • Test mitochondria from cells under mitoprotein-induced stress conditions, which should show increased MIX23 levels

  • Protein modification assays:

    • Perform alkylation experiments with mmPEG to verify the presence of disulfide bonds in the native protein

    • Compare the migration pattern of native MIX23 with cysteine mutants

  • Co-immunoprecipitation validation:

    • Verify interactions with known partner proteins in the IMS or components of the import machinery

These validation steps ensure that your antibody specifically recognizes the physiologically relevant form of MIX23 in its native environment.

How can MIX23 antibodies be used to investigate mitochondrial protein import defects?

MIX23 antibodies provide valuable tools for investigating mitochondrial protein import defects through several experimental approaches:

Comparative Import Analysis:
MIX23 levels are highly responsive to import defects, particularly in TIM23 machinery mutants. Researchers can use MIX23 antibodies to monitor protein levels under various conditions:

  • In temperature-sensitive tim17-5 mutants at permissive (25°C) and semi-permissive (33°C) temperatures

  • In cells overexpressing mitochondria-targeted proteins that induce import stress

  • In cells treated with compounds that affect mitochondrial membrane potential

Import Kinetics Assessment:
Using MIX23 antibodies in pulse-chase experiments can reveal:

  • Temporal dynamics of MIX23 upregulation during import stress

  • Correlation between MIX23 levels and import efficiency of matrix proteins

  • The relationship between proteasome induction and MIX23 upregulation

Synthetic Genetic Interaction Studies:
Based on the synthetic growth defect observed between Δmix23 and tim17-5 mutations , MIX23 antibodies can help monitor protein levels in various genetic backgrounds to identify new functional relationships within the import machinery.

The data obtained from tim17-5 Δmix23 double mutant studies showed that the import of Oxa1 and Atp1 was considerably reduced at elevated temperatures compared to single mutants, demonstrating MIX23's role in stabilizing protein translocation .

What methodologies can detect MIX23 upregulation during mitoprotein-induced stress?

Detection of MIX23 upregulation during mitoprotein-induced stress requires sensitive and quantitative approaches:

Transcript Level Analysis:

  • Quantitative RT-PCR to measure MIX23 transcript levels, which can increase more than 4-fold during stress conditions

  • RNA-seq analysis to place MIX23 upregulation in the context of global transcriptional responses

Protein Level Quantification:

  • Western blotting with MIX23 antibodies, using appropriate loading controls

  • Mass spectrometry-based proteomics to quantify relative abundance changes

Stress Induction Protocols:
Various experimental conditions can induce MIX23 upregulation:

Stress ConditionExpected MIX23 ResponseExperimental Timeframe
Cytochrome b₂-DHFR overexpression>4-fold increase in transcript4-8 hours post-induction
Cox11 overexpressionSignificant but lower induction6-12 hours post-induction
tim17-5 mutation at semi-permissive temperatureModerate increase2-4 hours after temperature shift
mia40-3 mutationMild effectVariable

Visualization Techniques:

  • Immunofluorescence microscopy to detect changes in MIX23 localization and abundance

  • Live-cell imaging with fluorescently tagged MIX23 to monitor dynamic responses

These methodologies provide complementary approaches to comprehensively characterize MIX23 upregulation during mitoprotein-induced stress conditions.

Why might my MIX23 antibody show cross-reactivity with other mitochondrial proteins?

Cross-reactivity of MIX23 antibodies with other mitochondrial proteins can occur for several reasons:

Structural Similarities:
MIX23 contains four conserved cysteine residues that form disulfide bonds , a feature shared with many other IMS proteins. This structural similarity can lead to epitope cross-recognition, particularly with:

  • Other Mia40 substrates in the IMS

  • Twin CX₃C and CX₉C proteins, despite their different cysteine pattern arrangement

Technical Factors Contributing to Cross-Reactivity:

  • Antibody generation against linear epitopes that become exposed in denatured proteins

  • Improper folding of recombinant antigens used for immunization

  • Incomplete absorption/pre-clearing of polyclonal antibodies

Mitigation Strategies:
To address cross-reactivity issues, consider the following methodological approaches:

  • Epitope Mapping and Refinement:

    • Identify specific regions unique to MIX23 through sequence alignment

    • Generate epitope-specific antibodies targeting these unique regions

    • Use biophysics-informed modeling to predict epitope accessibility and specificity

  • Validation in Knockout Controls:

    • Always include Δmix23 samples as negative controls

    • Use western blotting to identify any cross-reactive bands

  • Absorption Protocols:

    • Pre-absorb antibodies with mitochondrial extracts from Δmix23 strains

    • Perform sequential immunoprecipitation to deplete cross-reactive antibodies

  • Application-Specific Optimization:

    • Adjust antibody concentration and incubation conditions for each application

    • Optimize blocking conditions to minimize non-specific binding

Implementing these strategies can significantly improve antibody specificity and reduce cross-reactivity with other mitochondrial proteins.

How can contradictory results between different experiments using MIX23 antibodies be resolved?

Contradictory results when using MIX23 antibodies may stem from several sources and require systematic troubleshooting:

Common Sources of Contradictions:

  • Variation in MIX23 expression levels:

    • MIX23 is strongly upregulated under stress conditions, with transcript levels increasing more than 4-fold during mitoprotein-induced stress

    • Different growth conditions or genetic backgrounds may significantly alter baseline expression

  • Post-translational modifications:

    • Disulfide bond formation affects protein conformation and epitope accessibility

    • Potential additional modifications may occur under specific conditions

  • Technical variables:

    • Antibody lot-to-lot variation

    • Different fixation methods affecting epitope preservation

    • Variations in subcellular fractionation efficiency

Systematic Reconciliation Approach:

  • Standardized Controls Matrix:
    Create a control matrix that includes:

    • Wild-type samples under standard conditions

    • Δmix23 samples as negative controls

    • Samples with known upregulation (e.g., cells overexpressing cytochrome b₂-DHFR)

    • Temperature-sensitive tim17-5 mutants at permissive and semi-permissive temperatures

  • Multi-method Validation:
    Compare results across complementary techniques:

    TechniqueWhat It ConfirmsPotential Artifacts
    Western blotProtein size and abundanceDenaturation may affect epitope recognition
    ImmunofluorescenceLocalization and distributionFixation can alter epitope accessibility
    qRT-PCRTranscript levelsPost-transcriptional regulation may not reflect protein levels
    Mass spectrometryProtein identificationSample preparation biases
  • Epitope Mapping:

    • Determine which epitopes are recognized by different antibodies

    • Assess whether these epitopes are affected by protein conformation or modifications

  • Standardized Reporting:

    • Document all experimental conditions thoroughly

    • Report antibody source, catalog number, and lot

    • Include detailed methods for mitochondrial isolation and fractionation

By systematically addressing these factors, researchers can resolve contradictory results and establish reliable protocols for MIX23 antibody applications.

How might advanced antibody design techniques improve MIX23-specific antibodies?

Recent advances in antibody design can significantly enhance MIX23-specific antibodies:

Computational Antibody Design:
Biophysics-informed modeling approaches similar to those described for other antibody systems can be applied to MIX23 antibodies. These methods:

  • Identify different binding modes associated with particular epitopes

  • Predict antibody-antigen interactions with high specificity

  • Enable the computational design of antibodies with customized specificity profiles

The approach involves training models on experimentally selected antibodies and associating each potential epitope with a distinct binding mode, allowing for the generation of specific variants beyond those observed in experiments .

High-Throughput Selection Methods:
Phage display experiments with minimal antibody libraries can be used to select MIX23-specific binders . This approach:

  • Starts with a diverse library of potential antibody sequences

  • Selects for specific binding to recombinant MIX23

  • Uses next-generation sequencing to identify enriched sequences

  • Applies computational models to predict optimal candidates

Validation of Designer Antibodies:
Custom antibodies generated through these approaches should be validated through:

  • Binding affinity measurements using surface plasmon resonance

  • Specificity testing against wild-type and Δmix23 samples

  • Functional assays measuring the impact on MIX23-dependent processes

These advanced techniques provide a path toward developing next-generation MIX23 antibodies with enhanced specificity and reduced cross-reactivity.

What role might MIX23 antibodies play in understanding broader mitochondrial stress response mechanisms?

MIX23 antibodies can serve as powerful tools for investigating broader mitochondrial stress response mechanisms:

Integrated Stress Response Monitoring:
MIX23 is upregulated alongside proteasome subunits during mitoprotein-induced stress , suggesting its involvement in a coordinated stress response. MIX23 antibodies can help:

  • Track the temporal relationship between different components of the stress response

  • Identify regulatory factors that control both proteasome and MIX23 upregulation

  • Map signaling pathways connecting import defects to nuclear gene expression changes

Proteostasis Network Analysis:
By combining MIX23 antibodies with proteomics approaches, researchers can:

  • Identify protein interaction networks that change during stress conditions

  • Monitor how MIX23 levels correlate with the stability of other mitochondrial proteins

  • Track the degradation kinetics of proteins like Cox12, which is rapidly degraded in Mix23↑ mutants

Therapeutic Implications:
Understanding MIX23's role in mitochondrial stress responses may have implications for:

  • Neurodegenerative diseases involving mitochondrial dysfunction

  • Aging-related mitochondrial proteostasis decline

  • Cancer metabolism adaptations involving mitochondrial function

MIX23 antibodies provide a specific molecular tool to probe these broader physiological and pathological processes, potentially revealing new therapeutic targets for mitochondrial dysfunction.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.